Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 35 studies | 30% ± 12% | |
connective tissue cell | 7 studies | 32% ± 19% | |
microglial cell | 7 studies | 34% ± 9% | |
myofibroblast cell | 6 studies | 22% ± 10% | |
astrocyte | 5 studies | 24% ± 9% | |
type II pneumocyte | 5 studies | 21% ± 3% | |
smooth muscle cell | 4 studies | 26% ± 8% | |
adventitial cell | 3 studies | 28% ± 11% | |
pericyte | 3 studies | 20% ± 3% |
Insufficient scRNA-seq data for expression of MRC2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 100% | 14002.62 | 577 / 578 | 94% | 62.12 | 1081 / 1155 |
uterus | 100% | 13233.84 | 170 / 170 | 91% | 76.50 | 418 / 459 |
breast | 95% | 7057.92 | 437 / 459 | 95% | 81.56 | 1066 / 1118 |
ovary | 100% | 16978.68 | 180 / 180 | 88% | 50.49 | 379 / 430 |
prostate | 100% | 10194.11 | 245 / 245 | 87% | 29.56 | 436 / 502 |
esophagus | 97% | 6182.96 | 1395 / 1445 | 90% | 52.92 | 164 / 183 |
bladder | 95% | 6909.52 | 20 / 21 | 77% | 45.62 | 390 / 504 |
skin | 99% | 15479.79 | 1795 / 1809 | 65% | 43.13 | 308 / 472 |
thymus | 75% | 2711.03 | 492 / 653 | 86% | 99.80 | 518 / 605 |
intestine | 81% | 3823.25 | 785 / 966 | 72% | 31.95 | 378 / 527 |
kidney | 87% | 4342.97 | 77 / 89 | 56% | 24.62 | 505 / 901 |
stomach | 58% | 2676.54 | 209 / 359 | 77% | 36.39 | 221 / 286 |
brain | 27% | 667.44 | 711 / 2642 | 84% | 57.39 | 592 / 705 |
pancreas | 17% | 434.79 | 56 / 328 | 92% | 87.05 | 164 / 178 |
adrenal gland | 84% | 2508.83 | 218 / 258 | 24% | 12.73 | 56 / 230 |
tonsil | 0% | 0 | 0 / 0 | 100% | 59.93 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 17.34 | 1 / 1 |
spleen | 98% | 4860.26 | 237 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 97% | 10984.39 | 1294 / 1335 | 0% | 0 | 0 / 0 |
heart | 92% | 9143.91 | 789 / 861 | 0% | 0 | 0 / 0 |
adipose | 91% | 6416.01 | 1095 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 83% | 28.50 | 24 / 29 |
eye | 0% | 0 | 0 / 0 | 31% | 8.80 | 25 / 80 |
muscle | 27% | 744.24 | 213 / 803 | 0% | 0 | 0 / 0 |
liver | 4% | 104.37 | 9 / 226 | 19% | 7.28 | 77 / 406 |
peripheral blood | 2% | 32.42 | 15 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006897 | Biological process | endocytosis |
GO_0030574 | Biological process | collagen catabolic process |
GO_0001649 | Biological process | osteoblast differentiation |
GO_0016020 | Cellular component | membrane |
GO_0005925 | Cellular component | focal adhesion |
GO_0038023 | Molecular function | signaling receptor activity |
GO_0030246 | Molecular function | carbohydrate binding |
GO_0005518 | Molecular function | collagen binding |
GO_0005515 | Molecular function | protein binding |
Gene name | MRC2 |
Protein name | Mannose receptor C type 2 C-type mannose receptor 2 (C-type lectin domain family 13 member E) (Endocytic receptor 180) (Macrophage mannose receptor 2) (Urokinase-type plasminogen activator receptor-associated protein) (UPAR-associated protein) (Urokinase receptor-associated protein) (CD antigen CD280) |
Synonyms | ENDO180 CLEC13E KIAA0709 UPARAP |
Description | FUNCTION: May play a role as endocytotic lectin receptor displaying calcium-dependent lectin activity. Internalizes glycosylated ligands from the extracellular space for release in an endosomal compartment via clathrin-mediated endocytosis. May be involved in plasminogen activation system controlling the extracellular level of PLAUR/PLAU, and thus may regulate protease activity at the cell surface. May contribute to cellular uptake, remodeling and degradation of extracellular collagen matrices. May play a role during cancer progression as well as in other chronic tissue destructive diseases acting on collagen turnover. May participate in remodeling of extracellular matrix cooperating with the matrix metalloproteinases (MMPs). . |
Accessions | ENST00000446119.2 ENST00000579432.1 ENST00000584682.1 ENST00000303375.10 Q9UBG0 J3QQZ6 J3KRF1 E7EME3 |